Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population

Journal of Affective Disorders

Volumn 110, Issue 1-2, 2008, Pages 94-105

  Sihvo, Sinikka ^a   Isometsä, Erkki ^a,b   Kiviruusu, Olli ^a   Hämäläinen, Juha ^a   Suvisaari, Jaana ^a   Perälä, Jonna ^a   Pirkola, Sami ^a,b   Saarni, Samuli ^a   Lönnqvist, Jouko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antidepressant; Drug utilisation; General population; Pharmacoepidemiology; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; DRUG USE; DRUG UTILIZATION; FEMALE; FINLAND; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MORBIDITY; PAIN; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SHORT COURSE THERAPY; SLEEP DISORDER; TREATMENT INDICATION;

ADULT; AGE FACTORS; AGED; ALCOHOL-RELATED DISORDERS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DISABLED PERSONS; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; FINLAND; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PRESCRIPTIONS, DRUG; REGISTRIES; SINGLE PERSON;

EID: 47849094888     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.01.012     Document Type: Article

References (36)

1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am. J. Psychiatry 57 suppl4 (2000) 1-45. http://www.apa.org online access: www.apa.org
2. In: Aromaa A., and Koskinen S. (Eds). Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute B12/2004. Helsinki (2004). http://www.ktl.fi/health2000 Online access: www.ktl.fi/health2000
3. Balwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Davidson J.R.T., den Boer J.A., Fineberg N.A., Knapp M., Scott J., and Wittchen H.-U. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 19 (2005) 567-596
4. Beck C.A., Patten S.B., Williams J.V.A., Wang J.L., Currie S.R., Maxwell C.J., and El-Guebaly N. Antidepressant utilization in Canada. Soc. Psychiatr. Epidemiol. 40 (2005) 799-807
5. Brugha T.S., Bebbington P.E., Singleton N., Melzer D., Jenkins R., Lewis G., Farrell M., Bhugra D., Lee A., and Meltzer H. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br. J. Psychiatry 185 (2004) 378-384
6. Cooper C.C., Bebbington P., King M., Brugha T., Meltzer H., Bhugha D., and Jenkins R. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatr. Scand. 116 (2007) 47-53
7. Curtis L.H., Østbye T., Sendersky V., Hutchison S., Dans P.E., Wright A., Woosley R.L., and Schulman K.A. Inappropriate prescribing for the elderly Americans in a large outpatient population. Arch. Intern. Med. 164 (2004) 1621-1625
8. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur. Neuropsychotharmacol. 13 (2003) S69-S75
9. The Esemed/Mhedea 2000 investigators. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorder (ESEMeD) project. Acta Psychiatr. Scand. 109 suppl 420 (2004) 55-64
10. Gardarsdottir H., Heerdink E.R., Dijk van L., and Egberts A.C.G. Indications for antidepressant drug prescribing in general practice in the Netherlands. J. Affect Disord. 98 (2007) 109-115
11. Guaiana G., Andretta M., Corbari L., Mirandola M., Sorio A., D'Avanzo B., and Barbui C. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 66 (2005) 750-755
12. Helgason T., Tomasson H., and Zoega T. Antidepressants and public health in Iceland. Br J Psychiatry 184 (2004) 157-162
13. Henriksson S., Boethius G., Håkansson J., and Isacsson G. Indications for and outcome of antidepressant medication in a population: a prescription database and medical record study, in Jämtland county, Sweden, 1995. Acta Psychiatr Scand. 108 (2003) 427-431
14. Henriksson S., Asplund R., Boethius G., Hällström T., and Isacsson G. Infrequent use of antidepressants in depressed individuals (an interview and prescription database study in a defined Swedish population 2001-2002). Eur. Psychiatry 21 (2006) 355-360
15. Kessler R.C. The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective. J. Clin. Psychiatry 68 Suppl 2 (2007) 10-19
16. Korkeila J., Salminen J.K., Hiekkanen H., and Salokangas R.K.R. Use of antidepressants and suicide rate in Finland: an ecological study. J. Clin. Psychiatry 68 (2007) 505-511
17. Liljakumpu T., Hartikainen S., Klaukka T., Koponen H., Kivelä S.-L., and Isoaho R. Psychotropics among the home-dwelling elderly - increasing trends. Int. J. Geriatr. Psychiatry 17 (2002) 874-883
18. Lääketietokeskus. Pharmaca Fennica (2007), Lääketietokeskus Oy, Helsinki
19. Melartin T.K., Rytsälä H.J., Leskelä U.S., Lestelä-Mielonen P.S., Sokero P.T., and Isometsä E.T. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J. Clin. Psychiatry 66 (2005) 220-227
20. National Agency for Medicines and Social Insurance Institution. Finnish Statistics on Medicines 2006 (2007), Helsinki. http://www.nam.fi online access: www.nam.fi
21. NICE (National Institute for Health and Clinical Excellence). Anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical Guideline vol. 22 (2004). http://www.nice.org.uk online access: www.nice.org.uk
22. NICE (National Institute for Health and Clinical Excellence). Depression (amended) Management of depression in primary and secondary care. NICE Clinical Guide 23 (2007). http://www.nice.org.uk (amended). online access: www.nice.org.uk
23. Nomesco (Nordic Medico Statistical Committee). Medicines consumption in the Nordic countries 1999-2003.Nomesco, Copenhagen (2004). http://www.nom-nos.dk Online access: www.nom-nos.dk
24. O'Hayon M.M., Caulet M., Priest R.G., and Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J. lin. pidemiol 51 (1998) 273-283
25. Olfson M., Marcus S.C., Tedeschi M., and Wan G.J. Continuity of antidepressant treatment for adults with depression in the United States. Am. J. Psychiatry 163 (2006) 101-108
26. Patten S.B., Willliams J.V.A., Wang J.L., Adair C.E., Brant R., Casebeer A., and Barbui C. Antidepressant pharmacoepidemiology in a general population sample. J. Clin. Psychopharmacol. 25 (2005) 285-286
27. Patten S.B., Esposito E., and Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol. Drug Safety 16 (2007) 746-752
28. Paulose-Ram R., Safran M.A., Jonas B.S., Gu Q., and Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Safety 16 (2007) 560-570
29. Perälä J., Suvisaari J., Saarni S., Kuoppasalmi K., Isometsä E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppä T., Härkänen T., Koskinen S., and Lönnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 64 (2007) 19-28
30. Pirkola S., Isometsä E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., Koskinen S., Aromaa A., and Lönnqvist J.K. DSM-IV mood-. anxiety-, alcohol use disorders and their comorbidity in the Finnish adult population. Results from the Health 2000 Study. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005) 1-10
31. Sachs G.S., Nierenberg A.A., Calabrese J.R., Marangell L.B., Wisniewski S.R., Gyulai L., Friedman E.S., Bowden C.L., Fossey M.D., Ostacher M.J., Ketter T.A., Patel J., Hauser P., Rapport D., Martinez J.M., Allen M.H., Miklowitz D.J., Otto M.W., Dennehy E.B., and Thase M.E. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N. Engl. J. Med. 356 (2007) 1711-1722
32. Sihvo S., Sevon T., Haukka J., Hemminki E., Keskimäki I., Lumme S., McCallum A., and Wahlbeck K. Persistence of antidepressant use in Finland: a register-linkage study, 1994-2003. Pharmacoepidemiol. Drug Safety 15 (2006) S226-S227
33. Tiihonen J., Lönnqvist J., Wahlbeck K., Klaukka T., Tanskanen A., and Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63 (2006) 1358-1367
34. Trifirò G., Barbui C., Spina E., Moretti S., Tari M., Alacqua M., Caputi A.P., UVEC Group, and Arcoraci V. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol. Drug Safety 16 (2007) 552-559
35. Wang P.S., Lane M., Olfson M., Pincus H.A., Wells K.B., and Kessler R.C. Twelve-month use of mental health services in the United States. Arch. Gen. Psychiatry 62 (2005) 629-640
36. Wittchen H.U., Lachner G., Wunderlich U., and Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998) 568-578